What type of study is this?

This is a Cohort Study study (also classified as: Experimental Study, Quantitative Study).

October 9, 2025Circulation Research

Abstract Wed146: Generation and characterization of induced pluripotent stem cell-derived cardiomyocytes from uncontrolled diabetic patients with ischemic and non-ischemic cardiomyopathy

Q: What is the clinical evidence from this study?

Study design: Other. Population: Diabetic cardiomyopathy (n=3). Intervention: Diabetic ischemic and non-ischemic cardiomyopathy vs. Healthy control. Primary outcome: Electrophysiological properties (amplitude, APD80, MDP) and gene expression.

View Full Paper

Ask AI

Bookmark

Key result

Diabetic cardiomyopathy iPSC-CMs show altered electrophysiology with prolonged action potentials and reduced diastolic potential.

Authors

SCSung Woo ChoNational Institutes of Health HKHyoung Kyu KimInje University JHJin HanBeijing University of Chinese Medicine

Discussion

Member takes

Implication

This analysis reveals altered electrophysiological properties in iPSC-CMs from diabetic patients, suggesting new modeling avenues for cardiac conditions.

Key Points

Action potentials from iPSC-CMs showed significant differences, indicating altered electrical properties in diabetes patients.
RNA sequencing highlighted gene expression changes related to fibrosis and inflammation in diabetic cardiomyopathy.
Ischemic and non-ischemic patients both exhibited distinct cardiac cellular characteristics compared to controls.
These findings suggest iPSC-CMs could advance research in diabetic heart disease and drug discovery.

PICO

Population

3 individuals (a 27-year-old healthy female, a 56-year-old male with diabetic ICMP, and a 62-year-old male with diabetic Non-iCMP) whose cells were used to generate iPSC-CMs.

Exposure / Comparator

Diabetic ischemic and non-ischemic cardiomyopathy vs Healthy control

Primary Outcome

Electrophysiological properties (amplitude, APD80, MDP) and gene expression

Cite This Study

Cho et al. (2025) studied Diabetic cardiomyopathy (n=3). Diabetic ischemic and non-ischemic cardiomyopathy vs. Healthy control was evaluated on Electrophysiological properties (amplitude, APD80, MDP) and gene expression. iPSC-CMs from diabetic patients with ICMP and Non-iCMP exhibited significantly higher amplitude, prolonged APD80, and reduced maximum diastolic potential compared with healthy control cells.

synapsesocial.com/papers/68e77f09d1c187e1c108fb6e https://doi.org/10.1161/res.137.suppl_1.wed146

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals altered electrophysiological properties in iPSC-CMs from diabetic patients, suggesting new modeling avenues for cardiac conditions.

Abstract Wed146: Generation and characterization of induced pluripotent stem cell-derived cardiomyocytes from uncontrolled diabetic patients with ischemic and non-ischemic cardiomyopathy

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Abstract Wed146: Generation and characterization of induced pluripotent stem cell-derived cardiomyocytes from uncontrolled diabetic patients with ischemic and non-ischemic cardiomyopathy

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Also Consider